Record numbers expected to attend Umeå life science events in Stockholm

Umeå Biotech Incubator (UBI) is hosting two events in Stockholm later this week. Both the Meet Umeå Life Science and the Biotech Umeå Investment Day are expected to attract record numbers of participants.
“These events are a great way for us to connect life science companies from the Västerbotten region with national and international experts and investors. And this year a record number of participants have registered for the events, which feels amazing,“ says Jennie Ekbeck, CEO of Umeå Biotech Incubator.

Read more

Lipigon recruits new talent after multi-million SEK deal

Life science company Lipigon Pharmaceuticals has recruited two new members of staff following the signing of a multi-million SEK agreement for its gene therapy project with listed Nordic company CombiGene.
The new appointments will bring additional knowledge and skills to the Umeå-based company that will help it reach project milestones in the years ahead.
“This agreement allows us to grow, which is great for us and for Umeå,” says Stefan K Nilsson, CEO of Lipigon.

Read more

Umeå Biotech Incubator opens new office space in Umeå

Now Umeå Biotech Incubator is creating new business areas on Tvistevägen near Umeå University.
”It will be a new and modern co-working space for Umeå’s startups – where the companies can grow and collaborate,” says Jennie Ekbeck, CEO of Umeå Biotech Incubator.

Read more

Awarded millions in fight against antibiotic resistance

Researchers from the Umea pharmaceutical research company Quretech Bio have been granted SEK 5 million by the Erling-Persson Family Foundation to make resistant bacteria sensitive to antibiotics again.
“We are delighted and extremely grateful. This money is vital in allowing us to continue conducting critical experiments” says Jörgen Johansson, Professor of Molecular Microbiology at Umeå University and Co-founder of Quretech Bio.

Read more

Expert advisor enters Lipum

Now Umeå company Lipum brings more expertise to the company. Professor Anders Fasth steps in as an advisor in the development of medicines for inflammatory diseases.
“It is very gratifying that he joins the team,” says Einar Pontén, CEO of Lipum.

Read more

Lipigon signs multi-million gene therapy deal

Life science company Lipigon Pharmaceuticals has signed an agreement for its gene therapy project with listed company CombiGene.
“If everything goes well this agreement could potentially be worth millions. But it also enables us to develop our business in the short term, not least because we can now employ highly competent staff in Umeå,” says Stefan K Nilsson, CEO of Lipigon.

Read more

Spinchem shares 40 million SEK in research project

The Umeå company Spinchem shares about 40 million SEK in an international research project funded by the European Union.
”This is good timing for SpinChem since our strategy is to create new environmentally friendly, bio-based processes for industry,” says Emil Byström, CEO of Spinchem.

Read more

MetaCurUm Biotech wins innovation competition

MetaCurUm Biotech has won an innovation competition announced by Groth & Co. The price is an IPR consultation worth SEK 75,000.
”We are very happy and grateful for the prize. It is fantastic that the jury sees the potential in our idea and that they want to help us in our development,” says Lotta Berg, CEO of MetaCurUm Biotech.

Read more

​Three wins for life science at big business gala

When Umeå’s big business gala was held on November 7, three of twelve awards went to life science.
“Previously, life science had a relatively hidden role in Umeå – but during this year’s Umeågala we have proven that we are an industry that has great potential”, says Jennie Ekbeck, CEO of Umeå Biotech Incubator.

Read more

Umeå Biotech Incubator best in Sweden – advances to the Nordic final

​Umeå Biotech Incubator has been named the best in Sweden in the category Best Accelerator Program or Incubator Program – and thus goes on to the Nordic final in the prestigious Nordic Startup Awards.
“Now we keep our fingers crossed that as many people as possible votes for us. We aim to win the finals – and to move on to the global finals in China”, says Jennie Ekbeck, CEO at UBI.

Read more

Releasing online-education – to reduce the risk of serious sepsis

The start-up company Dianox, based in Umeå, is releasing a web-based education in clinical anaerobic bacteriology to teach biomedical scientists and other health and lab staff more about anaerobic bacteria. These bacteria can cause severe infections, that in the worst case can lead to fatal sepsis.

“The knowledge is inadequate in many hospitals and the universities address the problem of anaerobic bacteria to a limited extent. With more knowledge, hundreds of cases of serious blood poisoning can be avoided each year”, says Maria Hedberg, CEO at Dianox.

Read more

Brain Stimulation appoints new CEO

Umeå-based biotech company Brain Stimulation has appointed Fredrik Jonsson as its new CEO.
“Brain Stimulation has developed a fascinating and important product and now we want to concentrate on sales,” says Fredrik Jonsson.

Read more

More jobs to Umandiagnostics – after USA buyout

Following the $22.5 million acquisition this summer of Umeå-based UmanDiagnostics by major US biotech company Quanterix more people are now being hired at its offices in Umeå.
“Demand for our products is extremely high in the global marketplace and we’re probably looking at hiring even more people in the future”, says Niklas Norgren, CEO of UmanDiagnostics.

Read more